Sign in Pull a receipt

AKTX

Akari Therapeutics Plc

Healthcare · Biotechnology

$289.74 sample

+5.00 (+1.76%) 1D

Market cap

$551.7B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-03

Alerts

8

Price$289.74 +9.03% 3M daily closessample

289.74265.74

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 22INSInsider sell: EVP, Operations
Oct 15INSInsider sell: Chief Financial Officer
Oct 06INSInsider sell: Chief Executive Officer
Oct 01INSInsider buy: 10% owner
Sep 22INSInsider sell: 10% owner
Sep 14INSInsider sell: Chief Financial Officer
Sep 08INSInsider buy: Director
Sep 03SEC8-K filed: material event

Sign up to see the real AKTX record →

Company facts

SEC EDGAR registration

Name: Akari Therapeutics Plc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -41sample, -100 to +100
Reporting currency: USD

Who is positioning in AKTX

sample

Insiders: 35 insider transactions over 90 days, net selling, $311.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 6 funds hold $7.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$32.5B +15.3% y/y

Q4 2024Q3 2026

Inventory$19.3B +14.5% y/y

Q4 2024Q3 2026

Accounts receivable$14.9B +18.2% y/y

Q4 2024Q3 2026

Total debt$39.8B +22.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $230.8B +16.3% 3M
Sample peer B: $86.6B -2.4% 3M
Sample peer C: $72.8B +4.1% 3M
Sample peer D: $372.8B +4.1% 3M
Sample peer E: $106.4B +9.1% 3M